MedPath

Effect of Non-alcoholic Beer in Cirrhosis

Not Applicable
Completed
Conditions
Endothelial Dysfunction
Nutritional Status
Quality of Life
Interventions
Other: control
Dietary Supplement: Non-alcoholic beer
Registration Number
NCT04041115
Lead Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Brief Summary

The implementation of nutritional strategies targeting several variables at once could benefit patients with cirrhosis. Non-alcoholic beer has different compounds derived from hops that exert antioxidant, anti-inflammatory and nutritional properties. The aim of this study is to evaluate the effect of diet + exercise and non-alcoholic beer on nutritional status, endothelial function and quality of life in patients with cirrhosis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • Liver Cirrhosis of any aetiology (liver biopsy or a combination of clinical and biochemical variables plus evidence of portal hypertension); without decompensation during the past month; serum creatinine <1.5 mg%; able to attend the appointed visits and willing to participate in the study.
Exclusion Criteria
  • Severe concomitant cardiopulmonary diseases; decompensated type 2 Diabetes Mellitus, insulin use or proliferative diabetic retinopathy; orthopedic or osteomuscular limitations; any type of cancer; primary sclerosing cholangitis and inflammatory bowel disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Controlcontrolpersonalized nutritional therapy + aerobic exercise
Non-alcoholic BeerNon-alcoholic beernon-alcoholic beer + personalized nutritional therapy + aerobic exercise
Primary Outcome Measures
NameTimeMethod
Quality of life questionnaire8 weeks

Improvement in quality of life questionnaire CLDQ (chronic liver disease questionnaire)

Nutritional status8 weeks

improvement in impedance-derived phase angle (PhA)

Endothelial dysfunction8 weeks

improvement in serum markers of endothelial function (v.gr. nitric oxide, NO; prostacyclin, PGI2, etc.)

Changes in the heterogeneity of gut Microbiota8 weeks

Changes in the heterogeneity of fecal microbiota in terms of bacterial diversity will be assessed

Endothelial function8 weeks

improvement in flow-mediated dilation (brachial artery)

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath